Abbott gains following Q3 earnings report and FY21 guidance raise Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Akero Therapeutics (AKRO) up 10% after announcing that the FDA has granted fast track designation to its lead program investigating efruxifermin for the treatment of non-alcoholic steatohepatitis, or NASH
UP AFTER EARNINGS -
- Abbott (ABT) up 3%
- Biogen (BIIB) up 1%
- Winnebago (WGO) up 2%
- United Airlines (UAL) up 2%
DOWN AFTER EARNINGS -
- Netflix (NFLX) down 2%
- WD-40 (WDFC) down 10%
- Brinker (EAT) down 11%
LOWER -
- Novavax (NVAX) down 23% after Politico reported that the company has consistently run into production problems as the methods it used to test the purity of its Covid-19 vaccine have fallen short of regulators' standards
- Vinco Ventures (BBIG) down 13% after reporting changes to the roles of CEO Christopher Ferguson and CFO Brett Vroman and plans to change its name to Zash
Symbols:
AKRO ABT BIIB WGO UAL WDFC - $229.41 /
+0.265 (+0.12%)
NFLX EAT NVAX BBIG Keywords: Fly Intel, Wall Street, Top Stories, Stocks